FB
BIIB icon

Fulton Bank’s Biogen BIIB Stock Holding History

Fulton Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,048
Closed -$311K – 382
2019
Q4 		$311K Sell
1,048
-366
-26% -$102K 0.02% 327
2019
Q3 		$329K Buy
1,414
+215
+18% +$50.1K 0.02% 301
2019
Q2 		$281K Buy
1,199
+47
+4% +$10.9K 0.02% 335
2019
Q1 		$272K Sell
1,152
-63
-5% -$19.8K 0.02% 334
2018
Q4 		$366K Sell
1,215
-1,465
-55% -$468K 0.03% 290
2018
Q3 		$947K Buy
2,680
+12
+0.4% +$4.13K 0.06% 208
2018
Q2 		$775K Buy
2,668
+351
+15% +$98.7K 0.05% 218
2018
Q1 		$634K Buy
2,317
+752
+48% +$233K 0.04% 233
2017
Q4 		$498K Buy
1,565
+136
+10% +$43.6K 0.04% 273
2017
Q3 		$447K Buy
1,429
+297
+26% +$87.9K 0.03% 289
2017
Q2 		$307K Buy
+1,132
New +$299K 0.02% 348

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fulton Bank's BIIB Position: Q1 2020 in Review

Fulton Bank sold out of Biogen (BIIB) in Q1 2020, closing a stake of 1,048 shares — an estimated $311K sold.

Fulton Bank first reported a position in BIIB in Q2 2017 and held it in 11 quarters. The position peaked at $947K in Q3 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • Fulton Bank reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • Fulton Bank sold 1,048 Biogen shares in Q1 2020, an estimated $311K.
  • Fulton Bank first reported a position in Biogen in Q2 2017 and held it in 11 quarters.
  • Fulton Bank's Biogen position peaked at $947K in Q3 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on Fulton Bank's 13F filing for Q1 2020, filed 3 Apr 2020.